DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $2,188,000 | +121.0% | 58,619 | +50.4% | 0.34% | +54.3% |
| Q2 2020 | $990,000 | -21.8% | 38,983 | -43.4% | 0.22% | -44.3% |
| Q1 2020 | $1,266,000 | -66.4% | 68,915 | -59.7% | 0.39% | -52.6% |
| Q4 2019 | $3,769,000 | +889.2% | 171,088 | +379.6% | 0.83% | +704.9% |
| Q4 2018 | $381,000 | -47.2% | 35,673 | -24.6% | 0.10% | -3.7% |
| Q3 2018 | $722,000 | +24.7% | 47,286 | 0.0% | 0.11% | +17.6% |
| Q2 2018 | $579,000 | +28.1% | 47,286 | 0.0% | 0.09% | +21.3% |
| Q1 2018 | $452,000 | -22.2% | 47,286 | -26.5% | 0.08% | -27.9% |
| Q4 2017 | $581,000 | – | 64,340 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
| Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
| EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
| RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
| BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
| Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
| Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
| DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
| EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |